Lesson 26.4: Fair Value Committee Oversight

Where This Lesson Fits

The price verification process (Lesson 26.1) and stale price detection process (Lesson 26.3) are automated and analyst-driven controls that handle the routine valuation oversight for liquid, actively priced securities. Both processes have a defined escalation endpoint: when neither process can resolve a pricing question — because no current independent price is available, because the security is so illiquid that no market source exists, or because the pricing uncertainty is complex enough to require senior judgment — the matter is escalated to the Fair Value Committee.

The Fair Value Committee is the human governance layer of the valuation oversight system. It exercises authority over pricing decisions that automated systems and individual analysts cannot make: approving valuation models for Level 3 assets, reviewing quarterly fund NAVs for reasonableness, making fair value determinations when market prices are unavailable, and overseeing the overall quality and independence of the firm's valuation practices. Where Lessons 26.1 through 26.3 addressed the operational controls that prevent and detect valuation errors for the majority of the portfolio, this lesson addresses the governance structure that handles the minority of complex, high-judgment cases that those controls cannot resolve.

Understanding fair value committee governance is increasingly important for operations professionals because regulatory expectations for committee structure, independence, and documentation have grown significantly. SEC Rule 2a-5, which governs fair value determinations for registered investment companies, has established a detailed framework for board-designated valuation designees and fair value committees that reflects the SEC's view of what adequate valuation governance looks like — and whose principles are increasingly referenced in examination of investment advisers as well.

Lesson Objective

By the end of this lesson, students should be able to describe the purpose and authority of a fair value committee and explain why it is a required governance element for firms with Level 3 assets or complex valuation challenges; identify the composition requirements that ensure committee independence from portfolio management, and explain the conflict of interest risks that poor composition creates; describe the specific triggers that require escalation to the committee — including Level 3 asset reviews, stale price resolutions, pricing override approvals above threshold, and model validation reviews; explain the information required in a complete committee submission package and why each element is necessary for the committee's informed decision-making; describe the documentation and record-keeping requirements for committee decisions and explain their regulatory significance; identify the SEC Rule 2a-5 requirements for registered fund valuation governance and explain their broader relevance for investment adviser valuation practices; and evaluate a described fair value committee structure for adequacy of independence, meeting frequency, documentation quality, and escalation coverage.

Lesson Overview

A Fair Value Committee (also referred to as a Pricing Committee, Valuation Committee, or, in registered fund contexts, a Valuation Designee) is the governance body responsible for overseeing the firm's valuation practices and making fair value determinations for securities that cannot be priced through automated or analyst-level processes. The committee holds two distinct but related authorities: oversight authority (reviewing and approving the policies, methodologies, and procedures that govern the firm's valuation practices) and decision-making authority (making specific fair value determinations for individual securities when market prices are unavailable or inadequate).

The committee's effectiveness depends on three structural characteristics. First, independence: the committee must be composed of individuals who do not have a financial interest in the valuations they approve. Portfolio managers who earn performance fees based on reported asset values have an inherent conflict of interest in valuing the positions they manage. The committee must be structured to exclude, or at minimum constrain, the influence of investment personnel on valuation decisions. Second, expertise: the committee must have the analytical capability to evaluate the valuation methodologies and market inputs presented to it. A committee composed entirely of non-technical administrators may provide governance process without genuine analytical oversight. Third, regularity and documentation: the committee must meet with defined frequency, produce minutes that document the basis for each decision, and maintain records that allow a reviewer to reconstruct the committee's reasoning for any specific determination.

The regulatory framework for fair value committees has evolved significantly with the SEC's adoption of Rule 2a-5 under the Investment Company Act (effective 2022), which requires registered investment companies to designate a "valuation designee" responsible for fair value determinations and establishes specific requirements for the designee's oversight program. While Rule 2a-5 applies formally to registered funds rather than to investment advisers directly, its framework has become a reference point for SEC examination staff when reviewing the valuation governance of investment advisers managing client assets in similarly complex situations.

Why This Matters in Wealth & Asset Operations

The valuation of Level 3 assets — private equity, hedge fund interests, complex structured products, distressed securities, and other illiquid instruments — has been a recurring focus of SEC enforcement actions and examination findings. The concern is consistent across cases: investment managers who have discretion over the valuation of illiquid assets they manage, and who benefit financially from higher reported values through performance fees or AUM-based fees, may have incentives to report valuations that are more favorable than the facts support. Fair value committee governance is the structural mechanism that is supposed to prevent this outcome.

SEC enforcement actions in this area have targeted situations where: portfolio managers participated in valuation decisions for their own portfolios without adequate independent oversight; valuation methodologies were changed opportunistically to produce more favorable values; and committee meeting minutes were backdated or insufficiently detailed to demonstrate that genuine review occurred. The common theme is the absence of effective independence — the valuation process was controlled by individuals with conflicts of interest, and the committee governance was either absent or nominal.

For operations professionals who prepare committee submissions and implement committee decisions, understanding the governance requirements serves two purposes. First, it enables them to produce submission packages that give the committee a genuine basis for informed decision-making rather than simply ratifying whatever the pricing team proposes. Second, it enables them to identify committee governance weaknesses — poor composition, insufficient documentation, irregular meeting frequency, inadequate scope — and escalate these structural concerns to compliance before they produce examination findings or, worse, misstated client reporting.

Core Concept

Fair Value Committee — The governance body responsible for overseeing the firm's valuation practices and making fair value determinations for securities that cannot be priced through automated market sourcing or analyst-level processes. The committee holds both oversight authority (over valuation policies, models, and methodologies) and decision-making authority (over specific fair value determinations for individual securities). Its effectiveness depends on independence, expertise, regularity, and documentation quality.

Committee Independence — The structural separation of committee membership from portfolio management influence, achieved by excluding portfolio managers with financial interests in the valuations being reviewed from committee membership or, where exclusion is impractical, by ensuring that investment personnel are not the decision-making majority on valuation matters. Independence is the most critical structural characteristic of a fair value committee because it is the mechanism that prevents the conflict-of-interest risk inherent in manager-controlled valuation.

Valuation Designee (SEC Rule 2a-5) — Under SEC Rule 2a-5, registered investment companies must designate a "valuation designee" — either the fund's board or a designated person (typically the investment adviser) — to perform fair value determinations. Where the investment adviser serves as the valuation designee, the rule requires an oversight program with specific elements: periodic reporting to the board, a conflict of interest management program, and assessment of the fair value methodology's appropriateness on at least an annual basis. The valuation designee framework is the registered fund analog to the fair value committee structure at investment advisers.

Level 3 Asset Review — The periodic committee review of the valuation methodology, inputs, and assumptions applied to all Level 3 assets in client portfolios. Level 3 reviews are the committee's most significant recurring responsibility: they assess whether the fair value model remains appropriate for current market conditions, whether the model inputs are reasonable and current, and whether the resulting valuation accurately reflects what the asset could be sold for in a hypothetical market transaction. Level 3 reviews should occur at least quarterly for material positions.

Committee Minutes — The formal record of each committee meeting, documenting the valuations reviewed, the information presented, the analysis conducted, the determinations made, and the reasoning supporting each determination. Committee minutes are the primary governance documentation artifact: they allow a reviewer to reconstruct the committee's decision-making process for any specific valuation and to assess whether the committee's review was substantive rather than nominal. Minutes must be sufficiently detailed to demonstrate that genuine review occurred — not merely that a meeting took place.

Valuation Policy — The firm's written statement of valuation methodology, the hierarchy of pricing sources, the criteria for each level of the pricing hierarchy, the triggers for fair value committee review, and the process for approving and implementing fair value determinations. The valuation policy is the governance document that the fair value committee reviews and approves, and that operations staff implement. It must be updated when significant changes in markets, asset classes, or valuation methodologies make the existing policy inadequate.

Committee Structure: Composition, Authority, and Frequency

Effective fair value committee governance requires deliberate structural design across three dimensions: who sits on the committee (composition), what decisions the committee can make and must make (authority), and how often the committee meets and under what circumstances (frequency).

• Composition — Required Members. At minimum, the fair value committee should include representatives from: Operations or Portfolio Accounting (the function responsible for implementing pricing in the system and producing the submission packages), Risk Management (the function responsible for evaluating valuation model risk and market risk context), and Compliance (the function responsible for ensuring that the valuation process complies with regulatory requirements and the firm's own policies). The Chief Operating Officer or Chief Financial Officer typically chairs or co-chairs the committee, providing senior management accountability.
• Composition — Investment Personnel Exclusion or Constraint. Portfolio managers who manage positions being valued should not serve as voting members of the fair value committee for those positions. Where portfolio managers are included in committee deliberations — to provide market context or investment insight — they should be non-voting participants, and the final determination should be made by the non-investment members. This structural constraint is the primary independence mechanism: investment personnel may inform the committee's deliberations but must not control the determination.
• Authority — Mandatory Review Items. The committee's mandate should specify all items that require committee review and approval before being implemented in the portfolio system. Mandatory review items typically include: initial approval of the valuation methodology for any new Level 3 asset or asset class; periodic review of existing Level 3 valuations (at minimum quarterly, more frequently for material or volatile positions); approval of any fair value determination resulting from the stale price escalation process; approval of any price override above the material threshold where no market source can be confirmed; and annual review and approval of the firm's valuation policy.
• Authority — Escalation Receiving and Decision-Making. The committee's authority must be clearly defined relative to other decision-making bodies. The committee's determinations for specific valuations are final — they override the pricing team's initial assessment and the portfolio manager's input — and they are implemented without further approval except by the board (for registered funds) or senior management (for investment advisers). The committee must have the organizational standing to make valuations that investment personnel disagree with, without those personnel being able to reverse or override the committee's decision outside the committee process.
• Frequency — Regular and Ad Hoc Meetings. The committee must meet at a defined regular frequency — at minimum quarterly, to conduct Level 3 asset reviews — and must have the ability to convene ad hoc meetings for time-sensitive valuation decisions (stale price escalations, new Level 3 asset approvals, market disruption events). The trigger for ad hoc meetings should be defined in the committee charter, with a defined timeline for convening (for example, within 48 hours of a formal escalation from the pricing team). The committee's regular and ad hoc meeting schedule must be documented in the meeting calendar and archived with the committee minutes.

Escalation Triggers and Submission Package Requirements

The committee's decision-making quality depends on the quality of the information provided in each submission package. A committee that receives incomplete or poorly organized submissions cannot conduct substantive review regardless of its composition or independence. The following defines the triggers for committee escalation and the required contents of each submission package.

• Trigger 1 — New Level 3 Asset. Any new security that will be classified as Level 3 (model-based, unobservable inputs) requires committee approval of the valuation methodology before the first fair value determination is implemented. Submission package: security description and investment rationale, proposed valuation methodology with detailed description of inputs and assumptions, market context and comparable transactions if available, assessment of model limitations and uncertainty, and proposed review frequency for future committee updates. The committee approves, modifies, or rejects the proposed methodology; if rejected, the asset cannot be included in client portfolios until an acceptable methodology is approved.
• Trigger 2 — Quarterly Level 3 Review. Each Level 3 position requires a scheduled quarterly review to assess whether the valuation methodology remains appropriate and whether the current inputs and assumptions continue to reflect the best available estimate of fair value. Submission package: current valuation and last-approved valuation, description of material changes in the underlying investment or market conditions since the last review, updated model inputs with sources and justification, sensitivity analysis showing the impact of alternative assumptions, and any new information from the fund or investment (financial statements, independent audits, third-party appraisals). The committee approves the current valuation, modifies it, or requests additional information before approval.
• Trigger 3 — Stale Price Escalation. Any position escalated from the stale price resolution process because no current market price was obtainable requires committee determination. Submission package: position description and size, stale price in the system and its age, all alternative sources contacted and the result of each inquiry, market context (comparable security price changes, sector/index movements, news or events affecting the issuer), proposed fair value determination with methodology and reasoning, and the pricing team's recommended action. The committee approves the proposed fair value, modifies it, or requests a different sourcing approach.
• Trigger 4 — Model Validation Review. Any valuation model used for Level 3 assets requires periodic independent validation — a review of the model's mathematical correctness, its inputs' accuracy, and its outputs' reasonableness relative to market data. Model validation is typically performed annually for each active Level 3 model by a party independent of the model's developer (internal risk management, external valuation specialist, or audit). Submission package: validation report with findings and recommendations, proposed remediation for any findings, and assessment of the model's continued fitness for use. The committee approves the model's continued use, requires modifications, or suspends its use pending remediation.
• Trigger 5 — Material Price Override. Any price override above the material threshold that cannot be confirmed against an independent market source — where the pricing team has exercised judgment about the appropriate price rather than sourcing it directly from a market reference — requires committee approval before implementation. Submission package: the specific pricing question, the information available to inform the determination, the pricing team's proposed price and reasoning, alternative prices considered and rejected, and the financial impact on affected accounts. The committee approves the proposed override, modifies it, or requests additional information.

Substantive vs. Nominal Committee Review

The distinction between substantive and nominal committee review is the most consequential distinction in fair value committee governance. A committee that meets regularly, produces minutes, and approves valuations may be providing either genuine oversight or the appearance of oversight — and the difference is not always visible in the meeting calendar or the document archive.

Substantive committee review is characterized by genuine engagement with the specific information presented in each submission: the committee members read and understand the valuation analysis, identify assumptions that appear aggressive or unsupported, ask questions about market comparables and model inputs, and make an independent judgment about the valuation rather than ratifying whatever was proposed. Meeting minutes for substantive review reflect this engagement — they record the specific questions raised, the information provided in response, the alternatives considered, and the reasoning for the final determination. A reviewer reading the minutes can understand why the committee reached the conclusion it did.

Nominal committee review is characterized by the form of governance without its substance: the committee meets, submission packages are circulated, minutes are produced, and approvals are recorded — but the individual members have not genuinely engaged with the analysis. Minutes record that the committee "reviewed and approved" the valuation without any indication of what was discussed, what alternatives were considered, or why the proposed valuation was accepted. In enforcement actions involving inadequate valuation governance, this is the pattern most frequently described: a committee existed, it met, it produced minutes — but those minutes reveal that genuine independent review did not occur.

The practical test of substantive review is whether the committee has ever rejected or materially modified a proposed valuation. A committee that has approved 100% of submitted valuations without modification over multiple years may be providing genuine oversight — if the submissions are consistently well-supported — or it may be providing nominal oversight where challenge and independent judgment have been absent. Compliance oversight of the committee's track record of challenge and modification is a key indicator of whether the governance is substantive.

Operational Workflow: Preparing and Processing a Committee Submission

The following describes the workflow for preparing, submitting, and implementing a fair value committee decision for a quarterly Level 3 asset review — the most common recurring committee interaction for operations professionals.

1. Advance Data Collection. Two weeks before the quarterly committee meeting, the pricing team identifies all Level 3 assets in client portfolios requiring review. For each asset, the team collects: the current carrying value in the portfolio system, the valuation methodology last approved by the committee, the model's current inputs and their sources, financial statements or fund reports received since the last review, and any market data (comparable transactions, index movements, credit events) relevant to the asset's valuation.
2. Valuation Analysis Preparation. One week before the meeting, the pricing analyst prepares the valuation analysis for each asset: updating the valuation model with current inputs, running the model to produce a current fair value estimate, performing sensitivity analysis (showing how the fair value estimate changes when key assumptions are varied by defined amounts), and documenting the methodology, inputs, and reasoning in the submission package. For assets where the methodology has changed since the last review, the change is highlighted and the rationale is documented.
3. Submission Package Distribution. The complete submission packages for all items on the committee agenda are distributed to committee members at least three business days before the meeting. This lead time allows members to review the packages before the meeting rather than encountering the material for the first time in the meeting room. Members who have questions or concerns after reviewing the packages can submit them to the pricing team for clarification or additional information before the meeting.
4. Committee Meeting. The committee meets to review each submission. For each item, the presenting analyst (typically the pricing team member who prepared the analysis) provides a summary of the key findings, highlights any significant changes from the prior review, and answers committee members' questions. The committee discusses the analysis, considers alternative assumptions where relevant, and reaches a determination — approve the proposed valuation, approve with modification, request additional information before approval, or reject the proposed valuation and direct the pricing team to re-analyze using different assumptions.
5. Minutes Preparation and Approval. Within two business days of the committee meeting, a draft of the meeting minutes is prepared by the designated minute-taker (typically from the operations or compliance team). The minutes record: the date, attendees, agenda items, discussion summary for each item (including specific questions raised, information provided, and alternatives considered), and the determination and reasoning for each item. Draft minutes are circulated to committee members for review and correction; final minutes are approved at the following meeting or by circulation.
6. Determination Implementation. After the committee has approved a fair value determination, the pricing team implements the approved value in the portfolio accounting system through a documented price override. The override references the committee approval date and meeting number in its documentation, creating a direct link between the approved determination and its implementation. For determinations that modify the previously approved valuation, the modification is highlighted in the implementation record.
7. Follow-Up Items Tracking. Any item where the committee requested additional information before approval — or where conditions were attached to an approval — is tracked in a follow-up register. The follow-up register specifies the required information, the responsible party, and the deadline for providing the information. The committee reviews outstanding follow-up items at each subsequent meeting until all items are resolved.

Real-World Example

An SEC examination of a registered investment adviser managing $1.4 billion focuses on the firm's valuation governance for its allocation to private equity limited partnership interests, which represent approximately 18% of AUM and are classified entirely as Level 3. The examination team requests the fair value committee's meeting minutes, submission packages, and approval records for the prior two years.

The examination reveals a committee that formally exists — it has a defined membership list, it has met quarterly, and it has produced minutes — but whose governance is nominal rather than substantive. The meeting minutes consist of a one-paragraph record for each meeting indicating that the committee "reviewed and approved valuations as presented." There is no record of questions raised by committee members, no indication of which specific valuations were reviewed, no sensitivity analysis in the submission packages, and no documentation of the methodology applied to any of the Level 3 positions. Two portfolio managers who manage the private equity portfolios and receive performance fees on those assets are listed as committee members.

The examiners also find that the valuations for three large private equity positions have not changed for six consecutive quarters despite significant changes in comparable public market valuations and in the underlying companies' reported financial performance. When asked about the basis for holding the valuations constant, the pricing team cannot produce any analysis from the committee's records supporting that determination; the committee's minutes record only that the valuations were "reviewed and approved."

The examination results in a formal deficiency letter citing four findings: (1) the committee lacks independence due to portfolio manager membership; (2) the minutes are insufficient to demonstrate substantive review; (3) the submission packages lack valuation analysis adequate to support the committee's determinations; and (4) the static valuations for three positions are not supported by any documented analysis. The firm is required to restructure the committee, implement substantive documentation standards for meetings and submissions, and conduct an independent third-party valuation review of the three static-valued positions. The cost of the independent valuation review — significant both financially and operationally — significantly exceeds the cost of proper governance that would have prevented the finding.

Common Mistakes

Mistake 1: Including Portfolio Managers as Voting Members for Their Own Positions

The most consequential structural mistake in fair value committee design is allowing portfolio managers who have financial interests in the valuations being reviewed to serve as voting members. This is not a matter of intent — portfolio managers who genuinely believe their valuation is accurate and who vote to approve it may believe they are acting in good faith. The governance problem is structural: the same person cannot be both the advocate for a particular valuation (through their role as portfolio manager) and an independent assessor of that valuation's appropriateness (through their role as committee member). The conflict of interest exists regardless of intent.

Mistake 2: Producing Minutes That Are Too Brief to Demonstrate Review

Minutes that record only "the committee reviewed and approved valuations as presented" provide no evidence that any substantive review occurred. From an examination perspective, these minutes are functionally equivalent to a statement that a meeting took place — they do not demonstrate that the committee actually engaged with the specific valuations, identified any concerns, or exercised any independent judgment. Minutes must be sufficiently detailed to reconstruct the committee's analytical process for each determination.

Mistake 3: Failing to Review Level 3 Valuations When Comparable Market Conditions Change

The quarterly review schedule for Level 3 assets is a minimum, not a maximum. When significant changes in market conditions occur — a major credit event, a material change in interest rates, a significant development in a comparable company or sector — Level 3 valuations should be reviewed on an ad hoc basis even if the quarterly review date has not arrived. Holding a Level 3 valuation constant through a period of significant comparable market movement, without a documented committee review and determination that the constant valuation remains appropriate, is the pattern that most frequently attracts examination attention.

Mistake 4: Treating Committee Approval as the Final Step Without Follow-Up Tracking

When the committee approves a valuation with conditions — requesting additional information, requiring methodology changes by a defined date, or directing a third-party appraisal — those conditions must be tracked and confirmed as completed. A conditional approval that is implemented without completing the conditions is not a completed approval. The follow-up register and the subsequent meeting's review of outstanding items are the governance mechanisms that ensure conditional approvals are completed rather than implemented prematurely.

Mistake 5: Not Updating the Valuation Policy When Asset Classes or Methodologies Change

The valuation policy is the governance document that defines how the firm values its assets. When the firm adds new asset classes, changes its valuation methodology for existing assets, or adopts new pricing vendors, the valuation policy must be updated to reflect the current practice. A valuation policy that describes a methodology the firm no longer uses, or that does not address an asset class the firm now holds, is inaccurate governance documentation that will create examination findings when examined against current practice.

Practical Exercises

Exercise 1: Committee Composition Assessment

A registered investment adviser has the following fair value committee membership: Chief Investment Officer (CIO), two portfolio managers who manage the firm's private equity allocations, the CFO, the head of operations, and the chief compliance officer. The committee meets quarterly to review all Level 3 valuations. Assess this composition against the independence requirements described in this lesson and identify: (a) which members represent independence concerns and why; (b) the specific conflict of interest risks created by the current composition; (c) how the committee composition should be restructured to achieve adequate independence while maintaining appropriate expertise; and (d) whether the CIO's participation is appropriate and under what conditions.

Exercise 2: Submission Package Development

A private equity fund interest has been held in client portfolios for 18 months. The initial fair value at acquisition was $10 million (based on the purchase price). The fund has not yet provided a new NAV since the initial investment. Market conditions have changed since acquisition: comparable publicly traded companies in the same sector have declined approximately 22%, and leverage levels at comparable companies have increased. Develop a complete quarterly Level 3 review submission package for this position, including: (a) the proposed current fair value with methodology; (b) the inputs used and their sources; (c) the sensitivity analysis showing the impact of key assumption changes; (d) the specific market context information relevant to the valuation; and (e) the recommended review frequency going forward. Identify what additional information from the fund would strengthen the submission.

Exercise 3: Minutes Quality Assessment

Review the following two sets of meeting minutes and assess which demonstrates substantive review and which demonstrates nominal review. For each, identify the specific evidence that supports your assessment and specify what the weaker set of minutes should have included. Minutes Set A (for a Level 3 private credit position valued at $8.5 million): "The committee reviewed the valuation of the private credit position as presented by the pricing team. The committee approved the valuation of $8.5 million." Minutes Set B (for a Level 3 private credit position valued at $8.5 million): "The pricing team presented the updated valuation analysis for the private credit position. The committee reviewed the updated cash flow projections and discount rate assumptions. [Member] questioned the continued use of the original discount rate given the 75 basis point widening in comparable credit spreads since the position was established; the pricing team explained that the borrower's covenant compliance and recent interest payments support the view that credit risk has not materially changed. The committee directed the pricing team to source a broker quote from the loan's agent bank before the next quarterly review to provide additional market validation. Subject to receipt of the broker quote, the committee approved the current valuation of $8.5 million. The pricing team will report the broker quote finding at the next meeting." Explain what governance improvements Minutes A should implement and confirm which elements of Minutes B represent best practice.

Exercise 4: SEC Rule 2a-5 Application

A registered open-end mutual fund managed by an investment adviser has significant allocations to Level 3 assets (private placements, structured credit instruments, and real estate investment trusts with suspended trading). The fund's board is evaluating whether to designate the investment adviser as the valuation designee under SEC Rule 2a-5. Describe the oversight program that the investment adviser would need to implement as the valuation designee, including: (a) the reporting obligations to the fund board; (b) the conflict of interest management program required; (c) the periodic methodological assessment requirements; (d) the recordkeeping obligations; and (e) the criteria the board should use to assess the investment adviser's continued fitness to serve as the valuation designee. Identify the key operational changes that the adviser's pricing and operations functions would need to implement to support the Rule 2a-5 oversight program.

Key Terms

Fair Value Committee — The governance body responsible for overseeing the firm's valuation practices and making fair value determinations for securities that cannot be priced through automated market sourcing. Holds both oversight authority over policies and models and decision-making authority over specific valuations.

Committee Independence — The structural separation of committee membership from portfolio management influence, ensuring that individuals with financial interests in reported valuations do not control the valuation decisions for those positions.

Valuation Designee (SEC Rule 2a-5) — Under Rule 2a-5, the person or entity designated by a registered investment company's board to perform fair value determinations, typically the investment adviser. The designation carries specific oversight, reporting, and recordkeeping obligations.

Level 3 Asset Review — The periodic committee review of the valuation methodology, inputs, and assumptions for all Level 3 assets, conducted at minimum quarterly. The committee's primary recurring responsibility for complex and illiquid positions.

Committee Minutes — The formal record of each committee meeting documenting the specific valuations reviewed, the information presented, the analysis conducted, the questions raised and answered, the determinations made, and the reasoning supporting each determination.

Valuation Policy — The firm's written statement of valuation methodology, pricing hierarchy, criteria for each hierarchy level, triggers for fair value committee review, and procedures for implementing fair value determinations. Reviewed and approved by the committee at least annually.

Submission Package — The complete set of documents and analysis provided to the fair value committee for each agenda item, containing the information the committee needs to make an informed determination. Must include the proposed valuation, the methodology, the inputs and their sources, sensitivity analysis, and market context.

Substantive Review — Committee engagement that involves genuine analytical assessment of the submitted valuation — reading and understanding the analysis, identifying assumptions that appear aggressive, asking questions about comparables and inputs, and making an independent determination rather than ratifying the proposal.

Nominal Review — The form of committee governance without its substance — meetings are held, minutes are produced, approvals are recorded — but members have not genuinely engaged with the analysis and cannot exercise independent judgment about the appropriateness of proposed valuations.

Model Validation — The independent review of a valuation model's mathematical correctness, input accuracy, and output reasonableness, conducted by a party independent of the model's developer. Required periodically (typically annually) for all Level 3 valuation models and reviewed by the committee.

Follow-Up Register — A tracking document maintained between committee meetings that records all conditional approvals, requested information, and outstanding action items, with responsible parties and deadlines. Ensures that conditions attached to committee approvals are completed rather than prematurely implemented.

Conflict of Interest (Valuation) — The condition in which a person responsible for valuation determinations has a financial interest in the reported values — most commonly portfolio managers who receive performance fees based on AUM or returns calculated using reported asset values.

Knowledge Check

Question 1

Why must portfolio managers who receive performance fees tied to AUM or investment returns be excluded from voting on the fair value committee for positions they manage?

• A. Because portfolio managers lack the analytical expertise to assess valuation models
• B. Because portfolio managers with performance fees have a financial incentive to approve higher valuations — they benefit directly from higher reported values — creating a conflict of interest that prevents them from serving as independent assessors of valuation appropriateness
• C. Because SEC regulations prohibit portfolio managers from participating in any valuation discussions
• D. Because portfolio managers typically do not have enough time to serve on a valuation committee

Correct Answer: B — The conflict of interest is direct and structural: a portfolio manager whose compensation includes performance fees calculated on reported returns or AUM has a financial interest in higher reported valuations. This does not mean the manager will advocate for inflated values dishonestly — but even an honest manager faces an incentive structure that compromises their ability to serve as an objective, independent assessor of valuation appropriateness. The governance solution is structural exclusion (or non-voting participation) rather than reliance on individual integrity, because structural solutions work regardless of individual intent.

Question 2

A fair value committee has reviewed and approved valuations for six Level 3 private equity positions every quarter for two years without modifying any proposed valuation. What does this pattern suggest about the committee's review quality?

• A. The pricing team is producing high-quality analyses and the committee is functioning effectively
• B. The pattern may indicate nominal rather than substantive review — a committee that never challenges or modifies a proposed valuation may not be engaging analytically with the submissions; independent compliance review of the meeting minutes and submission packages is warranted to assess whether genuine review is occurring
• C. This is normal behavior — private equity valuations are stable and rarely need modification
• D. The committee should have a target for how frequently it modifies valuations as a governance metric

Correct Answer: B — While it is possible that a pricing team consistently produces well-supported analyses that do not require modification, a 100% approval rate over two years for complex, illiquid assets in a changing market environment is a pattern that warrants scrutiny. Private equity valuations are inherently uncertain and depend on assumptions that reasonable people can legitimately differ about; a committee that never identifies a reasonable alternative assumption, never requests additional information, and never reaches a determination different from the pricing team's proposal may not be exercising genuine independent judgment. Compliance review of the minutes and submission packages should assess whether the pattern reflects high-quality submissions or nominal review.

Question 3

What is the minimum information that must be included in a fair value committee submission package for a quarterly Level 3 asset review?

• A. The current carrying value and the proposed fair value, with the difference highlighted
• B. The current and proposed fair values, the valuation methodology with inputs and sources, a sensitivity analysis of key assumptions, material changes in the underlying investment or market conditions since the last review, and any new third-party information (financial statements, independent appraisals)
• C. A one-page summary prepared by the portfolio manager with their recommended valuation
• D. The prior quarter's committee-approved valuation and the pricing team's updated proposal

Correct Answer: B — The submission package must provide the committee with the information needed to make an independent, informed determination. This requires: the current valuation and the proposed update (to allow comparison), the full valuation methodology (to allow the committee to assess its appropriateness), the specific inputs used and their sources (to allow the committee to evaluate input quality), sensitivity analysis (to allow the committee to understand how sensitive the valuation is to key assumptions), and updated market context and third-party information (to allow the committee to assess whether the methodology remains appropriate given current conditions). A summary without this information cannot support genuine review.

Question 4

A fair value committee approves a Level 3 valuation subject to the condition that the pricing team obtain an independent broker quote for the position before the next quarterly meeting. The next quarterly meeting occurs, but no broker quote has been obtained. What should the committee do?

• A. Accept the valuation as approved at the prior meeting, since the approval was given
• B. Record the failure to complete the conditional requirement, direct the pricing team to obtain the broker quote within a defined deadline before it can be confirmed, and not treat the condition as satisfied until the broker quote is actually received and reviewed
• C. Re-approve the valuation unconditionally, since the pricing team did not find a reason to modify it
• D. Reject the prior approval entirely and require a new submission

Correct Answer: B — A conditional approval is not an unconditional approval until the condition is met. The committee's prior approval was explicitly contingent on receiving a broker quote; that condition has not been met. The committee should not treat the approval as complete, should document the outstanding condition in the follow-up register, should direct the pricing team to fulfill the condition within a specific deadline, and should review the broker quote when received before confirming the valuation. Treating a conditional approval as complete without the condition being fulfilled undermines the purpose of the condition and sets a precedent that conditions need not be completed.

Question 5

Under SEC Rule 2a-5, when an investment adviser serves as the valuation designee for a registered fund, to whom does the adviser report and with what frequency?

• A. To the SEC's Division of Investment Management, quarterly
• B. To the fund's board of directors, with the frequency and content specified in Rule 2a-5 — including prompt reporting of material valuation errors and periodic reporting on the valuation program's functioning, conflicts management, and significant developments
• C. To the fund's chief compliance officer, annually
• D. To FINRA, through its examination program

Correct Answer: B — Rule 2a-5 establishes that when the investment adviser is the valuation designee, it must report to the fund's board of directors, which retains ultimate oversight responsibility. Reporting includes: prompt notification of material valuation errors, periodic reporting on the valuation designee's activities (including conflicts of interest identified and managed), and at least annual assessment of the adequacy of the valuation methodologies and processes. The board uses this reporting to assess whether the adviser continues to perform adequately as the valuation designee and whether any changes to the oversight program are required.

Lesson Summary

The Fair Value Committee is the human governance layer of the valuation oversight system, exercising authority over valuation decisions that automated controls and individual analysts cannot make. Its effectiveness depends on three structural characteristics: independence (committee composition that excludes or constrains portfolio manager influence over valuations of their own positions), expertise (members capable of genuine analytical engagement with valuation methodologies), and regularity and documentation (defined meeting frequency, substantive minutes that record the committee's analytical process, and complete submission packages that provide the basis for informed determination).

Escalation triggers define when committee review is required: new Level 3 assets, quarterly Level 3 reviews, stale price escalations, model validations, and material price overrides without independent market confirmation. Each escalation requires a complete submission package containing the proposed valuation, the methodology and inputs, sensitivity analysis, and market context — the committee cannot conduct substantive review without this information. Committee determinations must be implemented through documented price overrides that reference the committee approval, creating a direct audit trail from determination to implementation.

The distinction between substantive and nominal review is the critical governance quality indicator. A committee that approves every submission without challenge, produces one-paragraph minutes without analytical detail, and has never directed the pricing team to modify a proposed valuation is providing nominal governance regardless of its formal structure. Compliance oversight of committee review quality — including review of minutes, submission packages, and the history of committee modifications — is the ongoing monitoring function that prevents nominal governance from masquerading as substantive oversight.

Looking Ahead

Lesson 26.5 examines Illiquid Asset Review Procedures — the specific operational processes applied to the most challenging segment of the valuation problem: assets with no active market, where independent market pricing is not available, where valuation depends entirely on models and management estimates, and where the fair value committee's oversight is most consequential. The procedures for illiquid asset review operationalize the committee governance framework described in this lesson, translating the committee's authority into specific data collection, analysis, and review workflows for private equity, hedge fund interests, real assets, and distressed securities.

Study Support

How to Approach This Lesson

The central analytical skill in this lesson is evaluating a described committee structure for adequacy — identifying independence failures, documentation gaps, and escalation coverage weaknesses. Practice this through the exercises, particularly the composition assessment (Exercise 1) and the minutes quality assessment (Exercise 3). The real-world example provides a complete illustration of what examination findings look like when governance is nominal rather than substantive; study it carefully as a checklist of what not to do.

Key Patterns to Recognize

• Portfolio managers with performance fees cannot be voting members for positions they manage — this is a structural independence requirement, not a matter of individual trustworthiness.
• Minutes that record only approval without analytical detail are functionally equivalent to no review record at all.
• A 100% approval rate without modification over a long period is a governance quality warning sign requiring scrutiny.
• Conditional approvals are incomplete until the condition is verified as met — they cannot be treated as unconditional at implementation.
• Level 3 valuations that do not change through periods of significant comparable market movement require documented committee review, not just continued use of the prior determination.

Practical Application

Application 1: Building the Fair Value Committee Charter

The fair value committee's authority, composition, procedures, and documentation requirements should be codified in a formal committee charter — a written governance document approved by senior management or the board. The charter specifies: the committee's mandate and decision-making authority; membership requirements and conflict-of-interest exclusion rules; the schedule of regular meetings and the triggers for ad hoc meetings; the required contents of submission packages for each trigger type; the format and required contents of meeting minutes; the follow-up register process; and the committee's reporting obligations to the board (for registered funds) or senior management. Operations professionals who are responsible for supporting the committee function should understand the charter in detail, as it defines their own obligations in preparing submissions and implementing determinations.

Application 2: Compliance Oversight of Committee Quality

The compliance function's oversight of the fair value committee is a distinct activity from the committee's own governance. Compliance should periodically review: whether the committee's composition continues to meet the independence requirements as personnel change; whether the submission packages provided are adequate to support substantive review; whether the minutes reflect genuine analytical engagement; whether conditional approvals are being tracked and completed; and whether the scope of the committee's review covers all Level 3 assets in current portfolios. This compliance review is not a substitute for the committee's self-governance but is the independent monitoring mechanism that detects governance weaknesses before they produce examination findings.

Application 3: Third-Party Valuation Services for Independent Validation

For firms with significant Level 3 exposures — particularly in asset classes like private equity, real estate, or complex structured credit — periodic engagement of an independent third-party valuation specialist provides a validation check on the committee's in-house determinations. Third-party valuation reports, prepared annually or semi-annually for material Level 3 positions, give the committee an external perspective that does not depend on the firm's own models and assumptions. These reports are among the strongest evidence of valuation independence available to demonstrate to examiners and auditors that the firm's Level 3 valuations are not purely self-assessed by parties with interests in the outcome.

Application 4: Connecting Committee Governance to the Exception Reporting System

The fair value committee's determinations feed directly into the exception reporting system described in Lesson 26.6: each price override implemented pursuant to a committee determination appears as a committee-approved exception in the exception log, and the exception log's summary of committee-approved overrides forms part of the monthly pricing quality report reviewed by senior management. This connection between the committee governance process and the exception reporting system creates an integrated view of pricing determinations — where automated verification produces some exceptions and committee governance produces others — that provides a complete audit trail of all pricing decisions made during the period.

Lesson Navigation